InvestorWire NewsRoom

Press Release

AIM ImmunoTech to Present at the Q1 Virtual Investor Summit on March 24th
March 11, 2021

AIM ImmunoTech to Present at the Q1 Virtual Investor Summit on March 24th

OCALA, Fla., March 11, 2021 (GLOBE NEWSWIRE) — via InvestorWire – AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, will be presenting at the Q1 Virtual Investor Summit.

  Event                                                Q1 Investor Summit

  Date                                                 March 23-25th, 2021

  Presentation                                   March 24th @ 3:00 PM ET


About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors. 

To request complimentary investor registration: please visit the following website at 

About AIM ImmunoTech Inc. 
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of
therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

Investor Relations Contact:
Crescendo Communications, LLC
Phone: 212-671-1021
Email: [email protected]

AIM ImmunoTech Inc
Phone: 800-778-4042
Email: [email protected]

Investor Summit Contact: 
Brittney Blocker at [email protected]

Wire Service Contact
InvestorWire (IW)
Los Angeles, California
212.418.1217 Office
[email protected]

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).